Search results
Lilly drug for Alzheimer’s approved by FDA
BioPharma Dive· 5 days agoThe drug, which Lilly will sell as Kinsunla, carries a warning for the risk of a certain kind of imaging abnormality that can be serious in rare cases.
Novo, Lilly fall after Biden calls for cheaper obesity drugs
CNBC Awaaz· 4 days agoNovo Nordisk A/S and Eli Lilly & Co. shares fell Tuesday after US President Joe Biden continued his...
Atossa Therapeutics updates protocol for breast cancer treatment trial
Clinical Trials Arena· 6 days agoAtossa Therapeutics has announced a protocol amendment in its ongoing clinical trial of...
Waiting for a wonder drug? The weight just got longer
The Economic Times· 3 days agoEli Lilly has yet to get the nod from India's drug regulator for selling its blockbuster drug...
Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
Pharmaceutical Technology· 4 days agoAs Eli Lilly’s Kisunla (donanemab) enters the Alzheimer's treatment space, its leading competitor...
New Alzheimer’s drug wins approval after FDA delay
Deseret News· 4 days agoA sign for Eli Lilly & Co. sits outside their corporate headquarters in Indianapolis on April 26, 2017. The U.S. Food and Drug Administration on Tuesday...
Govt panel urges drug regulator to approve Lilly's obesity drug Mounjaro
Business Standard India· 6 days agoAn Indian government-approved expert panel has advised the country's drug regulator to approve the...
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro
CNBC Awaaz· 6 days agoAn Indian government-approved expert panel has advised the country's drug regulator to approve the...
India panel urges drug regulator to approve Lilly's obesity drug Mounjaro - ET HealthWorld | Pharma
The Economic Times· 6 days agoHyderabad: An Indian government-approved expert panel has advised the country's drug regulator to...
Novo Nordisk must cut prices of weight-loss drug, Biden says in USA Today piece - ET HealthWorld |...
The Economic Times· 5 days agoWeight-loss Drug Price Cut: Biden and Sanders also said Eli Lilly was charging high prices for its...